Cargando…

Development and validation of the Treatment Related Impact Measure of Weight (TRIM-Weight)

BACKGROUND: The use of prescription anti-obesity medication (AOM) is becoming increasingly common as treatment options grow and become more accessible. However, AOM may not be without a wide range of potentially negative impacts on patient functioning and well being. The Treatment Related Impact Mea...

Descripción completa

Detalles Bibliográficos
Autores principales: Brod, Meryl, Hammer, Mette, Kragh, Nana, Lessard, Suzanne, Bushnell, Donald M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2841109/
https://www.ncbi.nlm.nih.gov/pubmed/20137088
http://dx.doi.org/10.1186/1477-7525-8-19
_version_ 1782179071744016384
author Brod, Meryl
Hammer, Mette
Kragh, Nana
Lessard, Suzanne
Bushnell, Donald M
author_facet Brod, Meryl
Hammer, Mette
Kragh, Nana
Lessard, Suzanne
Bushnell, Donald M
author_sort Brod, Meryl
collection PubMed
description BACKGROUND: The use of prescription anti-obesity medication (AOM) is becoming increasingly common as treatment options grow and become more accessible. However, AOM may not be without a wide range of potentially negative impacts on patient functioning and well being. The Treatment Related Impact Measure (TRIM-Weight) is an obesity treatment-specific patient reported outcomes (PRO) measure designed to assess the key impacts of prescription anti-obesity medication. This paper will present the validation findings for the TRIM-Weight. METHODS: The online validation battery survey was administered in four countries (the U.S., U.K., Australia, and Canada). Eligible subjects were over age eighteen, currently taking a prescription AOM and were currently or had been obese during their life. Validation analyses were conducted according to an a priori statistical analysis plan. Item level psychometric and conceptual criteria were used to refine and reduce the preliminary item pool and factor analysis to identify structural domains was performed. Reliability and validity testing was then performed and the minimally importance difference (MID) explored. RESULTS: Two hundred and eight subjects completed the survey. Twenty-one of the 43 items were dropped and a five-factor structure was achieved: Daily Life, Weight Management, Treatment Burden, Experience of Side Effects, and Psychological Health. A-priori criteria for internal consistency and test-retest coefficients for the total score and all five subscales were met. All pre-specified hypotheses for convergent and known group validity were also met with the exception of the domain of Daily Life (proven in an ad hoc analysis) as well as the 1/2 standard deviation threshold for the MID. CONCLUSION: The development and validation of the TRIM-Weight has been conducted according to well-defined principles for the creation of a PRO measure. Based on the evidence to date, the TRIM-Weight can be considered a brief, conceptually sound, valid and reliable PRO measure.
format Text
id pubmed-2841109
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28411092010-03-18 Development and validation of the Treatment Related Impact Measure of Weight (TRIM-Weight) Brod, Meryl Hammer, Mette Kragh, Nana Lessard, Suzanne Bushnell, Donald M Health Qual Life Outcomes Research BACKGROUND: The use of prescription anti-obesity medication (AOM) is becoming increasingly common as treatment options grow and become more accessible. However, AOM may not be without a wide range of potentially negative impacts on patient functioning and well being. The Treatment Related Impact Measure (TRIM-Weight) is an obesity treatment-specific patient reported outcomes (PRO) measure designed to assess the key impacts of prescription anti-obesity medication. This paper will present the validation findings for the TRIM-Weight. METHODS: The online validation battery survey was administered in four countries (the U.S., U.K., Australia, and Canada). Eligible subjects were over age eighteen, currently taking a prescription AOM and were currently or had been obese during their life. Validation analyses were conducted according to an a priori statistical analysis plan. Item level psychometric and conceptual criteria were used to refine and reduce the preliminary item pool and factor analysis to identify structural domains was performed. Reliability and validity testing was then performed and the minimally importance difference (MID) explored. RESULTS: Two hundred and eight subjects completed the survey. Twenty-one of the 43 items were dropped and a five-factor structure was achieved: Daily Life, Weight Management, Treatment Burden, Experience of Side Effects, and Psychological Health. A-priori criteria for internal consistency and test-retest coefficients for the total score and all five subscales were met. All pre-specified hypotheses for convergent and known group validity were also met with the exception of the domain of Daily Life (proven in an ad hoc analysis) as well as the 1/2 standard deviation threshold for the MID. CONCLUSION: The development and validation of the TRIM-Weight has been conducted according to well-defined principles for the creation of a PRO measure. Based on the evidence to date, the TRIM-Weight can be considered a brief, conceptually sound, valid and reliable PRO measure. BioMed Central 2010-02-05 /pmc/articles/PMC2841109/ /pubmed/20137088 http://dx.doi.org/10.1186/1477-7525-8-19 Text en Copyright ©2010 Brod et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Brod, Meryl
Hammer, Mette
Kragh, Nana
Lessard, Suzanne
Bushnell, Donald M
Development and validation of the Treatment Related Impact Measure of Weight (TRIM-Weight)
title Development and validation of the Treatment Related Impact Measure of Weight (TRIM-Weight)
title_full Development and validation of the Treatment Related Impact Measure of Weight (TRIM-Weight)
title_fullStr Development and validation of the Treatment Related Impact Measure of Weight (TRIM-Weight)
title_full_unstemmed Development and validation of the Treatment Related Impact Measure of Weight (TRIM-Weight)
title_short Development and validation of the Treatment Related Impact Measure of Weight (TRIM-Weight)
title_sort development and validation of the treatment related impact measure of weight (trim-weight)
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2841109/
https://www.ncbi.nlm.nih.gov/pubmed/20137088
http://dx.doi.org/10.1186/1477-7525-8-19
work_keys_str_mv AT brodmeryl developmentandvalidationofthetreatmentrelatedimpactmeasureofweighttrimweight
AT hammermette developmentandvalidationofthetreatmentrelatedimpactmeasureofweighttrimweight
AT kraghnana developmentandvalidationofthetreatmentrelatedimpactmeasureofweighttrimweight
AT lessardsuzanne developmentandvalidationofthetreatmentrelatedimpactmeasureofweighttrimweight
AT bushnelldonaldm developmentandvalidationofthetreatmentrelatedimpactmeasureofweighttrimweight